Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pankajini Mallick

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|May 25, 2017
Regulation of drug-metabolizing enzymes in infectious and inflammatory disease: implications for biologics-small molecule drug interactionsPankajini Mallick, Guncha Taneja, Bhagavatula Moorthy, et al.
Life Sciences|September 4, 2015
Impact of obesity on accumulation of the toxic irinotecan metabolite, SN-38, in micePankajini Mallick, Pranav Shah, Adarsh Gandhi, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 1, 2017
Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitroPankajini Mallick, Sumit Basu, Bhagavtula Moorthy, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2016
In Vitro Approaches to Study Regulation of Hepatic Cytochrome P450 (CYP) 3A Expression by Paclitaxel and RifampicinRomi Ghose, Pankajini Mallick, Guncha Taneja, et al.
Chemico-Biological Interactions|June 19, 2018
Impact of diet on irinotecan toxicity in micePankajini Mallick, Pranav Shah, Michael M Ittmann, et al.
Environmental Research|April 22, 2021
Using quantitative modeling tools to assess pharmacokinetic bias in epidemiological studies showing associations between biomarkers and health outcomes at low exposuresMelvin E Andersen, Pankajini Mallick, Harvey J Clewell, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 17, 2022
Biological system considerations for application of toxicogenomics in next-generation risk assessment and predictive toxicologyMichael B Black, Allysa Stern, Alina Efremenko, et al.
The AAPS Journal|January 5, 2020
The Evolving Druggability and Developability Space: Chemically Modified New Modalities and Emerging Small MoleculesWenzhan Yang, Prajakta Gadgil, Venkata R Krishnamurthy, et al.
Environmental Research|December 23, 2019
Quantitative bias analysis of the association between subclinical thyroid disease and two perfluoroalkyl substances in a single studyMichael W Dzierlenga, Marjory Moreau, Gina Song, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 19, 2020
Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With PyrethroidsPankajini Mallick, Gina Song, Alina Y Efremenko, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Metabolism & Toxicology|May 25, 2017
Regulation of drug-metabolizing enzymes in infectious and inflammatory disease: implications for biologics-small molecule drug interactionsPankajini Mallick, Guncha Taneja, Bhagavatula Moorthy, et al.
Life Sciences|September 4, 2015
Impact of obesity on accumulation of the toxic irinotecan metabolite, SN-38, in micePankajini Mallick, Pranav Shah, Adarsh Gandhi, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 1, 2017
Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitroPankajini Mallick, Sumit Basu, Bhagavtula Moorthy, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2016
In Vitro Approaches to Study Regulation of Hepatic Cytochrome P450 (CYP) 3A Expression by Paclitaxel and RifampicinRomi Ghose, Pankajini Mallick, Guncha Taneja, et al.
Chemico-Biological Interactions|June 19, 2018
Impact of diet on irinotecan toxicity in micePankajini Mallick, Pranav Shah, Michael M Ittmann, et al.
Environmental Research|April 22, 2021
Using quantitative modeling tools to assess pharmacokinetic bias in epidemiological studies showing associations between biomarkers and health outcomes at low exposuresMelvin E Andersen, Pankajini Mallick, Harvey J Clewell, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 17, 2022
Biological system considerations for application of toxicogenomics in next-generation risk assessment and predictive toxicologyMichael B Black, Allysa Stern, Alina Efremenko, et al.
The AAPS Journal|January 5, 2020
The Evolving Druggability and Developability Space: Chemically Modified New Modalities and Emerging Small MoleculesWenzhan Yang, Prajakta Gadgil, Venkata R Krishnamurthy, et al.
Environmental Research|December 23, 2019
Quantitative bias analysis of the association between subclinical thyroid disease and two perfluoroalkyl substances in a single studyMichael W Dzierlenga, Marjory Moreau, Gina Song, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 19, 2020
Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With PyrethroidsPankajini Mallick, Gina Song, Alina Y Efremenko, et al.
Pageof 2